Core A: Administration
核心A:管理
基本信息
- 批准号:8850624
- 负责人:
- 金额:$ 22.73万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2015
- 资助国家:美国
- 起止时间:2015-09-01 至 2020-08-31
- 项目状态:已结题
- 来源:
- 关键词:AdultAdvisory CommitteesAdvocateAmericanBasic ScienceChildClinicalClinical InvestigatorClinical ResearchClinical SciencesCollaborationsCommunicationCommunitiesComprehensive Cancer CenterCore FacilityDedicationsDevelopmentDiagnosticDoctor of PhilosophyEarly DiagnosisEngineeringEnsureFosteringGoalsGrantGroup MeetingsGuidelinesHumanInformation DisseminationInstitutesInvestigationIowaLaboratoriesLeadershipMalignant NeoplasmsMedicineMentorsNational Cancer InstituteNeuroendocrine TumorsOccupational activity of managing financesPatient CarePatientsPreventionPrincipal InvestigatorPublic HealthRecordsResearchResearch PersonnelResearch Project GrantsResearch SupportResource SharingResourcesReview CommitteeScienceScientistServicesSocietiesSpecialized Program of Research ExcellenceSupport GroupsTherapeuticTrainingTranslatingTranslational ResearchUniversitiesWorkWritingcareercareer developmentcollaborative environmentcollegedesignexperienceimprovedinnovationmeetingsmembernovel diagnosticsnovel therapeuticsorganizational structurepatient populationpersonalized medicineprogramssymposium
项目摘要
The overall goal of the Administrative Shared Resource for the Iowa Neuroendocrine Tumor SPORE (INET
SPORE) is to stimulate multi-disciplinary research in neuroendocrine tumors (NETs) and to translate these
observations and discoveries into personalized medicine for early detection of, curative treatments for, and
ultimately, the prevention of neuroendocrine tumors in adults and children. The Administration Core is
designed to serve as the organizational hub for the benefit of investigators, core directors, career and
developmental project awardees, and external investigators who seek to further our overall goals. The
Administrative Core will therefore provide an organizational structure designed to coordinate the activities of
the research projects, scientific cores, and developmental programs (Developmental Research Program,
Career Development Program) and will be responsible for coordinating the function of the SPORE committees
including the Executive Committee, the Internal Advisory Committee, and the External Advisory Committee. M
Sue O'Dorisio, MD, PhD, will serve as Director of the Administration Core, with James Howe, MD as Co-
Director. These senior investigators will now extend their collaborations to provide leadership and oversight of
SPORE activities in the following ways:
1) provide leadership, organizational support, and financial management to SPORE core directors and to
investigators for both major and developmental projects;
2) work with the Executive Committee to provide continual scientific review to select and support the most
promising full projects and developmental projects in accordance with SPORE guidelines;
3) foster career development for investigators dedicated to basic and clinical research in neuroendocrine
tumors;
4) provide oversight of SPORE Cores to ensure continual quality improvement in services for
investigators;
5) coordinate monthly investigator meetings, quarterly progress reviews by the internal review committee,
and a yearly review by the External review committee;
6) work with investigators and patient advocates to build new internal and external collaborations that will
expand access to comprehensive, state-of-the-art care for patients with neuroendocrine tumors;
7) disseminate new information from SPORE investigations to professionals and patient organizations
who care for patients with neuroendocrine tumors, as well as to the scientific community and the
public;
8) maintain timely communications with the National Cancer Institute.
9) Continually improve the overall Program Organization and Capabilities through excellent
communication and collaboration with the Holden Comprehensive Cancer Center (HCCC), the Iowa
Institute for Clinical & Translational Sciences (ICTS), and the Colleges of Medicine, Engineering, and
Public Health
爱荷华州神经内分泌肿瘤孢子(INET)管理共享资源的总体目标
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
M. Sue O'Dorisio其他文献
M. Sue O'Dorisio的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('M. Sue O'Dorisio', 18)}}的其他基金
Neuroendocrine Tumor Specialized Programs of Research Excellence (SPORE) in Human Cancer
人类癌症神经内分泌肿瘤卓越研究专门计划 (SPORE)
- 批准号:
10264523 - 财政年份:2015
- 资助金额:
$ 22.73万 - 项目类别:
Neuroendocrine Tumor Specialized Programs of Research Excellence (SPORE) in Human Cancer
人类癌症神经内分泌肿瘤卓越研究专门计划 (SPORE)
- 批准号:
9342676 - 财政年份:2015
- 资助金额:
$ 22.73万 - 项目类别:
Neuroendocrine Tumor Specialized Programs of Research Excellence (SPORE) in Human Cancer
人类癌症神经内分泌肿瘤卓越研究专门计划 (SPORE)
- 批准号:
8850619 - 财政年份:2015
- 资助金额:
$ 22.73万 - 项目类别:
Dosimetry Guided Phase II of 90Y-DOTA-tyr3-Octreotide + Retinoic Acid in Kids
90Y-DOTA-tyr3-奥曲肽视黄酸儿童剂量测定指导 II 期试验
- 批准号:
7749337 - 财政年份:2009
- 资助金额:
$ 22.73万 - 项目类别:
90Y-DOTA-TYR3-OCTREOTIDE ADMINISTERED TO CHILDREN WITH REFRACTORY TUMORS
90Y-DOTA-TYR3-奥曲肽治疗难治性肿瘤儿童
- 批准号:
7604807 - 财政年份:2007
- 资助金额:
$ 22.73万 - 项目类别:
CPTK787/ZK222584 IN PATIENTS WITH METASTATIC NEUROENDOCRINE TUMORS
CPTK787/ZK222584 在转移性神经内分泌肿瘤患者中的应用
- 批准号:
7604868 - 财政年份:2007
- 资助金额:
$ 22.73万 - 项目类别:
CPTK787/ZK222584 IN PATIENTS WITH METASTATIC NEUROENDOCRINE TUMORS
CPTK787/ZK222584 在转移性神经内分泌肿瘤患者中的应用
- 批准号:
7377088 - 财政年份:2006
- 资助金额:
$ 22.73万 - 项目类别:
90Y-DOTA-TYR3-OCTREOTIDE ADMINISTERED TO CHILDREN WITH REFRACTORY TUMORS
90Y-DOTA-TYR3-奥曲肽治疗难治性肿瘤儿童
- 批准号:
7376989 - 财政年份:2006
- 资助金额:
$ 22.73万 - 项目类别:
相似海外基金
Toward a Political Theory of Bioethics: Participation, Representation, and Deliberation on Federal Bioethics Advisory Committees
迈向生命伦理学的政治理论:联邦生命伦理学咨询委员会的参与、代表和审议
- 批准号:
0451289 - 财政年份:2005
- 资助金额:
$ 22.73万 - 项目类别:
Standard Grant